GH1 and Turner syndrome: In Turner syndrome, a retrospective series found that girls receiving high-dose PEG-GH (0.2 mg/kg/week) achieved Δheight SDS and height velocity comparable to those on daily GH (0.38 mg/kg/week), both of which exceeded the outcomes of a lower-dose group [30].